GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EyeGene Inc (XKRX:185490) » Definitions » Marketable Securities

EyeGene (XKRX:185490) Marketable Securities : ₩31,122 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is EyeGene Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. EyeGene's Marketable Securities for the quarter that ended in Dec. 2024 was ₩31,122 Mil.

EyeGene's annual Marketable Securities declined from Dec. 2022 (₩64,409 Mil) to Dec. 2023 (₩49,872 Mil) and declined from Dec. 2023 (₩49,872 Mil) to Dec. 2024 (₩31,122 Mil).


EyeGene Marketable Securities Historical Data

The historical data trend for EyeGene's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EyeGene Marketable Securities Chart

EyeGene Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29,626.34 82,707.47 64,408.54 49,872.00 31,122.00

EyeGene Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49,872.00 39,750.23 35,888.42 34,366.53 31,122.00

EyeGene Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


EyeGene  (XKRX:185490) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


EyeGene Marketable Securities Related Terms

Thank you for viewing the detailed overview of EyeGene's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


EyeGene Business Description

Traded in Other Exchanges
N/A
Address
Gangseo-gu, Seoul 401, B-dong 910 Gayang-dong, Seoul, KOR, 07528
EyeGene Inc is a South Korea based bio-venture company. It researches and develops biopharmaceuticals. Its products include EG-Mirotin, EG-HPV, EGVac systems. It provides drugs for the treatment of age-related degenerative diseases. Its products target diabetic retinopathy.

EyeGene Headlines

No Headlines